Health

Results: 265-276 of 4405

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

PR Newswire associated0

Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India

PR Newswire associated0

Lorena Cosmetics Holdings SPV Announces Acquisition and Re-Launch of The Harley Medical Group & sk:n Clinic Group

PR Newswire associated0

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax

PR Newswire associated0

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

Norwegian healthcare region expands enterprise imaging contract with Sectra--digitizes pathology diagnostics to improve cancer care

Kester Capital backs experienced management team in acquiring EMAS Pharma

Bionical Emas sells EMAS Pharma to Kester Capital following strategic review

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update

PR Newswire associated0

EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

IMFINZI (DURVALUMAB) IN COMBINATION WITH CHEMOTHERAPY RECEIVES POSITIVE RECOMMENDATION FROM THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE FOR PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER